MMP2 rs243865: Understanding the Promoter Variant
The rs243865 variant is a single nucleotide polymorphism located in the promoter region of the MMP2 gene. It is frequently studied for its potential influence on the transcriptional activity of matrix metalloproteinase-2, a protein involved in tissue remodeling and various health conditions.
What each genotype means
Baseline MMP2 activity
This genotype represents the common form of the MMP2 promoter region. Research suggests this version may be associated with lower transcriptional activity of the MMP2 enzyme compared to the T allele, potentially resulting in different rates of extracellular matrix turnover.
This is the most common genotype in most global populations, including those of European ancestry.
Intermediate MMP2 activity
Carrying one copy of the T allele may lead to increased transcriptional activity of the MMP2 gene. Some studies have linked this variant to markers of arterial stiffness and structural changes in heart valves, though findings across different health conditions remain mixed and limited.
Carried by a significant portion of the population, with the T allele frequency observed at approximately 0.20 in European populations.
Increased MMP2 activity
This genotype is associated with higher transcriptional activity of the MMP2 enzyme, which may contribute to increased extracellular matrix degradation. While some research links this to higher risks of arterial stiffness or specific heart valve conditions, other studies show no significant association with various diseases, indicating that the clinical impact is not fully established.
This is the least common genotype, occurring less frequently than the CC or CT combinations in most populations.
What is rs243865?
The variant rs243865 is a well-documented single nucleotide polymorphism (SNP) situated on chromosome 16. Specifically, it is located in the promoter region of the MMP2 gene, which acts as a regulatory switch for the gene's expression. In genetic nomenclature, this variant is often referred to as the -1306C>T polymorphism, indicating a substitution where a cytosine (C) is replaced by a thymine (T) at a specific position upstream of the gene's coding sequence. Because this change occurs in a regulatory area rather than the protein-coding portion of the gene, it is hypothesized to affect how much MMP2 protein is produced by cells rather than changing the structure of the protein itself. Researchers track this SNP to understand how subtle variations in DNA sequence can lead to differences in biological processes, such as the breakdown and reconstruction of the extracellular matrix that supports our tissues.
The Role of the MMP2 Gene
The MMP2 gene provides instructions for creating an enzyme called matrix metalloproteinase-2. This enzyme belongs to a family of proteins that are essential for breaking down collagen and other components of the extracellular matrix, the structural framework that surrounds cells. By remodeling this matrix, MMP2 plays a critical role in normal physiological processes, including wound healing, bone development, and the maintenance of blood vessel integrity. However, because of its ability to degrade tissue barriers, MMP2 is also a subject of intense interest in studies regarding how cells migrate and interact with their environment. When the regulation of this gene is altered, it may theoretically impact how tissues respond to injury or stress. Understanding the function of MMP2 is central to interpreting why variants in its promoter region, like rs243865, are investigated for their potential links to complex health outcomes.
Research and Evidence Strength
Scientific research into rs243865 has explored its association with various health conditions, including cardiovascular disease, stroke, and tumor susceptibility. However, the evidence linking this specific variant to these outcomes remains limited and often inconsistent. For instance, some studies have investigated whether the T allele influences functional outcomes after a stroke or susceptibility to inflammatory conditions like rheumatoid arthritis, but results have frequently failed to show a definitive or strong causal link. Other research has examined its role in cancer progression, such as in melanoma, yet these studies have also yielded mixed findings. It is important to recognize that many of these associations are statistical in nature and have not been consistently replicated across diverse populations. Consequently, the current scientific consensus does not support using this variant as a reliable predictor for individual health risks, as the biological impact of this promoter change appears to be subtle and highly dependent on other genetic and environmental factors.
Interpreting Your Genetic Information
If you have received information about your rs243865 genotype, it is essential to view it within the context of current scientific limitations. Because the evidence for this variant is not robust, it cannot be used to diagnose, predict, or guide medical treatment for any condition. Genetic variants often work in concert with thousands of other genes and lifestyle factors, meaning that a single SNP rarely determines a health outcome on its own. You should never make changes to your health regimen or medical care based on this information. If you have concerns about your cardiovascular health or other conditions mentioned in research, the most effective approach is to consult with a qualified healthcare provider. They can evaluate your overall health profile, family history, and clinical symptoms to provide personalized guidance that is far more accurate than any single genetic marker.
How common is this variant?
The minor T allele for rs243865 has a frequency of approximately 0.20 in European populations, though this can vary across different global ancestries.
Frequently asked questions
Is rs243865 a diagnostic test for heart disease?
No, rs243865 is not a diagnostic test. While it has been studied in the context of cardiovascular research, the evidence is not strong enough to predict individual risk or diagnose any heart-related condition.
Does the T allele cause cancer?
There is no evidence that the T allele causes cancer. Some studies have explored its role in tumor susceptibility, but results have been inconsistent and do not establish a direct causal relationship.
Can I change my MMP2 expression through diet?
There is no scientifically validated way to specifically target or alter the expression of the MMP2 gene through diet. Maintaining a healthy lifestyle is generally recommended for overall well-being, but it is not a treatment for genetic variants.
Where can I find more information about my specific genotype?
You can look up your variant in public databases like dbSNP or ClinVar for technical details. However, for health-related questions, you should always speak with a doctor or a genetic counselor who can interpret your results in the context of your full medical history.
Sources & further reading
Educational information only, last refreshed 9/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs243865?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29